Hepatocellular carcinoma (HCC) is the third leading cause of death from cancer worldwide but is often diagnosed at an advanced incurable stage. Yet, despite the urgent need for blood-based biomarkers for early detection, ...
Feb 12, 2024
0
0
Hepatocellular carcinoma (HCC) is a common human disease and one of the main causes of cancer-related death. The angiogenesis inhibitor Sorafenib (SORA) is commonly used in the treatment of advanced HCC as a first-line drug.
Feb 7, 2024
0
0
When asked about what could cause cancer, people most likely think of chemicals like tobacco or radiation such as UV light in sunshine, but chronic jet lag probably does not come to mind. Human epidemiological studies have ...
Feb 7, 2024
0
47
More than two-thirds of patients with hepatocellular carcinoma (HCC) who receive surgical interventions experience recurrence owing to lack of an established perioperative treatment. Now, researchers from Korea University ...
Feb 6, 2024
0
0
A joint research team has used stem cells to generate human immune cells for application in cancer immunotherapy. By replicating the natural process through which our bodies generate immune cells, this breakthrough platform ...
Feb 6, 2024
0
44
For centuries, doctors have used their hands as essential diagnostic tools—exploring joints and palpating abdomens to assess a patient's health. Often a cancer will reveal itself as a lump or unusual stiffness in a normally ...
Feb 1, 2024
0
13
With nearly 10 million deaths and nearly 20 million new cases in 2022, cancer remains one of the world's biggest killers, according to a report on Thursday by the World Health Organization.
Feb 1, 2024
0
0
Drinking alcohol—even in moderation—can take a serious toll on the body. According to the National Cancer Institute, there is a strong scientific consensus that drinking alcohol increases the risk for several types of ...
Jan 30, 2024
0
1
A team of researchers has found a causal link between the presence of oncofetal ecosystems (re-emergence of fetal program/features driven by the tumor) in the primary liver cancer hepatocellular carcinoma (HCC) and cancer ...
Jan 30, 2024
0
0
Ozempic and other GLP1 agonists are associated with a reduced risk of developing cirrhosis and liver cancer in people with type 2 diabetes and chronic liver disease, according to a nationwide study from Karolinska Institutet ...
Jan 23, 2024
0
89
